VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
40 hedge funds and large institutions have $82.6M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 11 closing their positions.
16% more capital invested
Capital invested by funds: $71.2M → $82.6M (+$11.3M)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding
Funds holding: 40 → 40 (0)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$26.1M |
| 2 |
Blackstone Inc
New York
|
+$4.92M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$3.87M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$3.29M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
+$3.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$656K |
| 2 |
ECM
Element Capital Management
New York
|
-$314K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$155K |
| 4 |
Renaissance Technologies
New York
|
-$155K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$155K |
VBIV Hedge Fund Activity: Q4 2018 in Review
40 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2018, worth a combined $82.6M — up 16% from $71.2M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VBIV positions and 11 closed out — a net gain of 1 holder — while 10 added to existing stakes and 11 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $26.1M. The largest seller was Vanguard Group, cutting an estimated $656K.
- 40 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $82.6M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2018, up 16% quarter-over-quarter.
- 12 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2018 and 11 closed out, a net change of +1 holder.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2018 was Perceptive Advisors, an estimated $26.1M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2018 was Vanguard Group, an estimated $656K sold.
Based on aggregated 13F filings for Q4 2018.